Rice Hall James & Associates LLC Reduces Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Rice Hall James & Associates LLC decreased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 550,812 shares of the company's stock after selling 22,722 shares during the period. Prestige Consumer Healthcare comprises about 2.4% of Rice Hall James & Associates LLC's holdings, making the stock its 7th largest holding. Rice Hall James & Associates LLC owned about 1.12% of Prestige Consumer Healthcare worth $43,013,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also added to or reduced their stakes in PBH. Kestra Investment Management LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter valued at approximately $27,000. nVerses Capital LLC raised its stake in shares of Prestige Consumer Healthcare by 200.0% during the third quarter. nVerses Capital LLC now owns 600 shares of the company's stock valued at $43,000 after acquiring an additional 400 shares during the last quarter. Huntington National Bank raised its stake in shares of Prestige Consumer Healthcare by 39.9% during the third quarter. Huntington National Bank now owns 635 shares of the company's stock valued at $46,000 after acquiring an additional 181 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of Prestige Consumer Healthcare by 7,112.5% during the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company's stock valued at $83,000 after acquiring an additional 1,138 shares during the last quarter. Finally, Covestor Ltd raised its stake in shares of Prestige Consumer Healthcare by 95.6% during the third quarter. Covestor Ltd now owns 1,338 shares of the company's stock valued at $96,000 after acquiring an additional 654 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Down 0.1 %

NYSE:PBH traded down $0.13 during trading hours on Friday, reaching $84.66. The company had a trading volume of 294,102 shares, compared to its average volume of 313,679. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 19.83, a P/E/G ratio of 2.69 and a beta of 0.50. The business's 50-day simple moving average is $79.42 and its two-hundred day simple moving average is $76.38. Prestige Consumer Healthcare Inc. has a twelve month low of $62.35 and a twelve month high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently issued reports on PBH. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Friday, January 24th. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Canaccord Genuity Group raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Finally, Oppenheimer increased their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $92.60.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.